Monday, October 04, 2010

Male Menopause: Another Treatment for Pharmaceutical Companies

The Washington Post came out with a long article today about how researchers, doctors, and drug companies are looking at something new to treat: male menopause, or as the article describes it, 'manopause'. There will always be a new and different condition that will require some sort of cure or treatment. I'm looking for a treatment for 'acute poor trading syndrome.'

But seriously, the big pharmas have plenty of drugs in the pipeline. And while you are wating for the bid payoff, you can always receive a dividend, as according to, there are about ten high yield big pharmaceutical stocks, and half of them have yields over 3%.

Eli Lilly & Co. (LLY) trades at eight times forward earnings and sports an extremely generous yield of 5.4%. Earnings were up 16% for the latest quarter and the company's next earnings announcement will be October 21.

Merck & Co., Inc. (MRK) trades at around nine times forward earnings and pays a yield of 4.1%. Earnings were down over 51% for the latest quarter, however, revenues almost doubled. Latest earnings announcement will be October 29.

To see a free recently updated list of all the high yield large pharmaceutical stocks, that can be downloaded and sorted, go to

Disclosure: Author did not own any of the above at the time it was written.


No comments: